LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.79 USD
-0.12 (-6.28%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $1.78 -0.01 (-0.56%) 6:18 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/27/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 92.00% |
ABR | 1.00 |
Earnings ESP
|
-15.15% |
---|---|
Current Year | -1.27 |
Next Year | -1.57 |
EPS (TTM) | -1.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 7.00M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 7.00M | NA |
Low Estimate | NA | NA | 7.00M | NA |
Year ago Sales | 5.14M | 0.05M | 6.77M | 7.00M |
Year over Year Growth Est. | NA | NA | 3.41% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.34 | -1.27 | -1.57 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.38 | -0.39 | -1.21 | -1.47 |
High Estimate | -0.28 | -0.28 | -1.17 | -1.47 |
Low Estimate | -0.38 | -0.39 | -1.43 | -1.66 |
Year ago EPS | -0.48 | -0.34 | -1.57 | -1.27 |
Year over Year Growth Est. | 31.25% | 0.00% | 19.11% | -23.62% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.33 | -0.34 | -1.27 | -1.57 |
7 Days Ago | -0.33 | -0.34 | -1.27 | -1.57 |
30 Days Ago | -0.34 | -0.35 | -1.30 | -1.59 |
60 Days Ago | -0.41 | -0.43 | -1.41 | -1.77 |
90 Days Ago | -0.41 | -0.43 | -1.41 | -1.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.39 | -1.21 | -1.47 |
Zacks Consensus Estimate | -0.33 | -0.34 | -1.27 | -1.57 |
Earnings ESP | -15.15% | -16.42% | 4.72% | 6.37% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | -0.24 | -0.34 | -0.48 | NA |
Estimate | -0.25 | 0.16 | -0.48 | -0.48 | NA |
Difference | 0.23 | -0.40 | 0.14 | 0.00 | -0.01 |
Surprise | 92.00% | -250.00% | 29.17% | 0.00% | -32.21% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more